Karagiannidis, Christian http://orcid.org/0000-0003-3247-2849
Slutsky, Arthur S.
Bein, Thomas
Windisch, Wolfram
Weber-Carstens, Steffen
Brodie, Daniel
Article History
Received: 29 October 2021
Accepted: 17 November 2021
First Online: 29 November 2021
Change Date: 12 May 2022
Change Type: Update
Change Details: The Open Access funding by Projekt DEAL was not included in the original publication, this article has been updated.
Declarations
:
: The study was approved by the Ethics Committee of the Witten/Herdecke University.
: All authors approved the final draft of the manuscript and gave their consent for publication.
: CK reports personal fees from Maquet, personal fees from Xenios, personal fees from Bayer, non-financial support from Speaker of the German register of ICUs, grants from the German Ministry of Research and Education, during the conduct of the study. TB, WW and SWC have nothing to disclose. AS reports personal fees from Baxter and Xenios in relation to consulting with respect to ECMO. DB receives research support from ALung Technologies. He has been on the medical advisory boards for Baxter, Abiomed, Xenios and Cellenkos.